Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BAT1706 vs EU Avastin in Advanced Non-Squamous NSCLC
NCT03329911Phase 3Completed
- Sponsor
- Bio-Thera Solutions, Ltd.
- Start
- Oct 2017
- Primary completion
- Nov 2019
- Modality
- RNA Aptamers, DNA Aptamers
- Countries
- 5
01
Overview
A Phase 3 trial of avacincaptad pegol in Nonsquamous Non-Small Cell Lung Cancer (nsNSCLC), sponsored by Bio-Thera Solutions, Ltd.. Started Oct 2017; status: completed.
02
Drugs
avacincaptad pegol
03
Conditions
Nonsquamous Non-Small Cell Lung Cancer (nsNSCLC)
Beyond the preview
Go deeper on NCT03329911.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03329911.